Computed tomography screening for lung cancer without a smoking cessation program-not a cost-effective idea

Journal of Thoracic Oncology

Volumn 6, Issue 11, 2011, Pages 1781-1783

  Evans, W K ^a,b,c   Wolfson, Michael C ^a,b,c  

^a MCMASTER UNIVERSITY   (Canada)

^b HAMILTON HEALTH SCIENCES   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER GROWTH; CANCER REGISTRY; CANCER SCREENING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; HUMAN; LUNG CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SMOKING CESSATION; SMOKING CESSATION PROGRAM; SURVIVAL RATE;

EID: 80054912076     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e3182344007     Document Type: Editorial

References (10)

1. The National Lung Screening Trial Research Team, Aberle DR, Adams AM, Berg CD, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365: 395-409.
2. Jemal A, Siegel R, Xu J, et al. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300
3. Erratum in CA Cancer J Clin 2011;61:133-134.
4. Tammemagi MC, Lam S, McWilliams A, et al. Incremental value of pulmonary function and sputum DNA image cytometry in lung cancer risk prediction. Cancer Prev Res 2011;4:552-561.
5. IASLC'S 2011 Statement on CT Screening for Lung Cancer. Available at: http://iaslc.technetrics.com/policies/statement-on-ct-screening/. Accessed August 15, 2011.
6. McMahon P, Kong CY, Bouzan C, et al. Cost-effectiveness of CT screening for lung cancer in the U.S. J Thorac Oncol 2011;6:1841-1848.
7. Cipriano LE, Romanus D, Earle CC, et al. lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992- to 2003. Value Health 2010;14:41-52.
8. Rock VJ, Malarcher A, Kahende JW, et al. Cigarette smoking among adults-United States 2006. MMWR Morb Mortal Wkly Rep 2007;56: 1157-1161.
9. Stout NK, Rosenverg MA, Trentham-Dietz A, et al. Retrospective cost-effectiveness analysis of screening mammography. J Natl Cancer Inst 2006;98:774-782. (Pubitemid 43983301)
10. Pignone M, Saha S, Hoerger T, et al. Cost-effectiveness analyses of colorectal cancer screening: a systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:96-104. (Pubitemid 34779153)